Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: K-Dur 20 – CAFC: Pay-for-delay...
A month ago we launched ipstrategy.com – the free online IP Strategy journal. The idea is simple – to provide quality thinking on IP Strategy across the globe from a wide...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: EWHC (Pat): Glatiramer acetate patent...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: Fortamet (Metformin) – US: CAFC again...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: SD New York: Copaxone patents...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: Parties and amici file briefs...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: Biological inventions – EPO Enlarged...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: European Parliament calls for curtailing...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: World Health Assembly: Agreement reached...
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: CAFC: Judge Newman again questions...
You must be logged in to post a comment.